project id: TCGA-STAD; case submitter id: TCGA-CD-A4MJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.79; rna integrity number: 8.8; age at index: 60; days to birth: -21932; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1951; age at diagnosis: 21932; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 384.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 448; days to sample procurement: 0; initial weight: 360.0; portion submitter id: TCGA-CD-A4MJ-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 38.0; percent tumor cells: 60.0; percent tumor nuclei: 75.0;